16th July 2019
Collaborating with new partners in science for further innovation
EIT Health Spain welcomes the Barcelona Institute of Science and Technology (BIST) as a new core partner and Ferrer as a new associate partner. The Barcelona Institute of Science and Technology (BIST) is a scientific initiative of seven of Catalonia’s research centres of excellence whose objective is to increase levels of collaboration in order to build a joint scientific project. Its strength is based on the research capacities of the seven centres and its potential to promote multidisciplinary, cutting-edge projects. Its scientific community is made up of members of the participating research centres:
Centre for Genomic Regulation (CRG), Institute for Bioengineering of Catalonia (IBEC), Institute of Photonic Sciences (ICFO), Institute of Chemical Research of Catalonia (ICIQ), Catalan Institute for Nanoscience and Nanotechnology (ICN2), High Energy Physics Institute (IFAE), and the Institute for Research in Biomedicine (IRB Barcelona). BIST’s mission is to promote excellent research in a multidisciplinary environment.
Ferrer, who has recently rejoined EIT Health after a short period out of the consortium, is a pharmaceutical Company whose Innovation is based on collaborations. They are proactive in establishing strategic alliances with hospitals, biotech companies, public research bodies, academic institutions and other pharmaceutical companies all over the world. With 20 years of experience in healthcare, Ferrer trusts in building partnerships, sharing know-how and expertise, and exploring synergies to advance scientific research and meet the increasing challenges involved in the development of new treatments. They are interested in both private and public expert partners in their areas of work (drug therapy, diagnostic, cardiovascular preventions, schizophrenia, bipolar disorders, and cancer) and in the technological sector in order to provide patients with comprehensive solutions.
On the other hand, PAU Education, an associate partner of EIT Health Spain since the beginning and a key participant promoting Innolife as part of EIT Health, has decided to leave the partnership. EIT Health Spain is grateful to Pierre-Antoine Ullmo, alma mater of PAU, for his great work, especially during the start-up phase of EIT Health. We wish PAU great success in all their endeavours.
For any additional information visit the EIT Health Spain page.
Click here for more information on BIST.
Click here for more information of Ferrer.
For further enquiries contact:
Lara Herbosa, email@example.com
EIT Health helps Tubulis secure €10.7M in funding
Investor Network aids firm doing antibody work
EIT Health-backed start-ups garner big investments
A million each for iLoF and Restorative Neurotechnologies
EIT Health aids 11 start-ups disrupted by COVID-19
Start-up Rescue Instrument gives €5.5M in co-investment